Fundraising Fox

Nanovis

Columbia City, US · 1 known investors

nanovistechnology.com ↗

Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.

BiotechMedical DevicesNew Materialsin /nanovis

Founders & leadership

BE
Brian EmerickChairman of Board
MH
Matthew HedrickChief Executive Officer and President
BM
Brian MoreChief Financial Officer
SG
Steve GerrishBoard Member

Investors · 1

Elevate VenturesIndianapolis · $20K – $2M

Reported raises · per SEC filings

Form D private placements
▶$5.4MraisedMar 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CHRISTOPHER LAMOTHEDirector
  • V. EDWARD GROGGDirector
  • BRIAN EMERICKExecutive Officer, Director
  • MATTHEW HEDRICKExecutive Officer, Director
  • BRIAN MOREExecutive Officer, Director
Amount sold
$5.4M
Minimum investment
$50K
Sales commissions
$220K
Proceeds to insiders
$237K
Placement agents
COMMENDA SECURITIES, LLC
First sale
Feb 2020
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$769.5KraisedSep 2017 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HedrickExecutive Officer, Director
  • Brian EmerickDirector, Promoter
  • v Edward GroggDirector
  • Brian MoreExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$769.5K
Minimum investment
$50K
Sales commissions
$440K
Proceeds to insiders
$237K
Placement agents
Commenda Securities, LLC
First sale
Aug 2017
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$1.1MraisedSep 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HedrickExecutive Officer, Director
  • Brian EmerickDirector, Promoter
  • V. Edward GroggDirector
  • Brian MoreExecutive Officer, Director
  • Steve GerrishDirector
Offering amount
$2.8M
Amount sold
$1.1M
Minimum investment
$100K
Proceeds to insiders
$30K
First sale
Sep 2016
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$3.8MofferedSep 2016 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve GerrishDirector
  • Brian EmerickDirector, Promoter
  • Brian MoreExecutive Officer, Director
  • Matthew HedrickExecutive Officer, Director
  • V. Edward GroggDirector
Offering amount
$3.8M
Minimum investment
$50K
Proceeds to insiders
$100K
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$750KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian MoreExecutive Officer
  • Steve GerrishDirector
  • Matthew HedrickExecutive Officer, Promoter
  • V. Edward GroggDirector
  • Brian EmerickDirector, Promoter
Offering amount
$2.5M
Amount sold
$750K
Minimum investment
$50K
Proceeds to insiders
$75K
First sale
Nov 2015
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian EmerickDirector, Promoter
  • Matthew HedrickExecutive Officer, Director, Promoter
  • Brian MoreExecutive Officer, Director
  • Steve GerrishDirector
Offering amount
$3.8M
Amount sold
$2.5M
Minimum investment
$50K
Proceeds to insiders
$122.5K
First sale
Dec 2014
Incorporated
Limited Liability Company, Indiana
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.